With the growing adoption of Full Field Digital Mammography (FFDM) systems at breast imaging facilities of all sizes, FUJIFILM Medical Systems USA has introduced Synapse version 3.2, the next planned release of Fuji's PACS which will include additional digital mammography capabilities. A core component to Fuji's complete acquisition-to-archive diagnostic solution for women's healthcare imaging, Synapse v. 3.2 is being introduced on the heels of the FDA approval of Fuji's FCRm FFDM system, and will further assist facilities with the unique workflow, visualization and image processing needs that the interpretation of FFDM studies presents.

Digital Mammography has a unique workflow that includes screening and diagnostic workflows, as well as the critical need for comparison models, multi-modality display capabilities and the integration of CAD results. Fuji's Synapse v. 3.2 will extend Fuji's unique Reading Protocol technology to enable reader-specific preferences to be set, providing for efficient and consistent screening workflows, and the flexibility to accommodate the unique challenges presented by diagnostic exams. And because Synapse is a multi-modality tool, not just a mammography tool, FFDM data can be integrated into the existing continuum of women's health care imaging that includes ultrasound and MR, while still using these reader-specific preferences.

While many PACS can readily display mammography images, Fuji has gone a step further and developed a new class of visualization tools focused on other digital diagnostic breast screening examinations. Synapse 3.2 will provide specific features to enhance the presentation of this critical image data, such as support for MQSA compliant overlays, the integration of CAD into the technologist and radiologist workflow, and support for Fuji's high quality AON compression algorithm.
"Modalities like Multi-slice CT began a paradigm shift in the way volumetric data is interpreted and managed, but now FFDM has assumed center stage and is presenting unique challenges to the digital transformation with its highly regulated nature and specific workflow requirements," said Bob Cooke, Fuji's Executive Director of Marketing and Product Development. "FFDM is driving change for radiology, and while digital mammography will certainly benefit from the experience the industry has gained in dealing with advanced softcopy interpretation, it also presents many new visualization challenges. With a rich history in digital transformations, a full product portfolio-including FFDM-and the introduction of Synapse v. 3.2, Fuji is best prepared to deliver a unique solution for any FFDM facility."

More Industry Headlines